Gefitinib

In vial of 0.5 g net

TargetMol Chemicals Inc.

Product Overview

Product / Grade Name

Gefitinib

Product Description

Gefitinib (ZD1839) is an EGFR first-generation inhibitor with oral activity that inhibits the EGFR 19 Del and L858R mutations. Gefitinib has antitumor activity and is used for the treatment of EGFR-mutated non-small-cell lung cancers. Gefitinib administration RESULTS in the development of the EGFR C797S resistance mutation.

Hazard Classification

  • UN Number

    :

  • IMGD Class

    :

  • Packing Group

    :

Visual Overview

Corporate Video